SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-054905
Filing Date
2012-08-07
Accepted
2012-08-07 08:00:58
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-13751_110q.htm 10-Q 997049
2 EX-10.19 a12-13751_1ex10d19.htm EX-10.19 150025
3 EX-10.30 a12-13751_1ex10d30.htm EX-10.30 138547
4 EX-31.1 a12-13751_1ex31d1.htm EX-31.1 13507
5 EX-31.2 a12-13751_1ex31d2.htm EX-31.2 12753
6 EX-32.1 a12-13751_1ex32d1.htm EX-32.1 7046
  Complete submission text file 0001104659-12-054905.txt   5594372

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rigl-20120630.xml EX-101.INS 790889
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rigl-20120630.xsd EX-101.SCH 37442
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rigl-20120630_cal.xml EX-101.CAL 30589
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rigl-20120630_lab.xml EX-101.LAB 528179
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rigl-20120630_pre.xml EX-101.PRE 240014
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rigl-20120630_def.xml EX-101.DEF 168389
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 121011323
SIC: 2834 Pharmaceutical Preparations